We recently compiled a list of the 10 Worst Performing Software Stocks to Buy According to Analysts. In this article, we are going to take a look at where Vertex, Inc. (NASDAQ:VERX) stands against the ...
Vertex (NASDAQ:VERX – Free Report) had its target price trimmed by Jefferies Financial Group from $62.00 to $48.00 in a ...
Vertex has backed out of its in vivo gene editing collaboration with Verve Therapeuti | Vertex has backed out of its in vivo ...
The stock's rise snapped a four-day losing streak.
Stifel Nicolaus downgraded shares of Vertex (NASDAQ:VERX – Free Report) from a buy rating to a hold rating in a report ...
Vertex, Inc. (VERX) has disclosed a new risk, in the Debt & Financing category. Vertex, Inc. faces significant financial risk in the event of a ...
BMO Capital analyst Daniel Jester lowered the firm’s price target on Vertex (VERX) to $41 from $56 and keeps a Market Perform rating on the shares. The firm had previously indicated that shares had ...
Jefferies lowered the firm’s price target on Vertex (VERX) to $48 from $62 and keeps a Buy rating on the shares. The company’s results beat on ...
The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies ...
Following testing by DNV at a rooftop project in the Italian city of Milan during January, it concluded that Trinasolar’s ...
Stifel analyst Brad Reback downgraded Vertex (VERX) to Hold from Buy with a price target of $31, down from $58. The company posted solid Q4 ...